Protaryx Medical Announces First U.S. Commercial Cases With Its Transseptal Puncture Device
Protaryx Medical has successfully completed its first U.S. commercial cases using the Protaryx Transseptal Puncture Device at UC Davis Health, performed by interventional cardiologist Dr. Gagan D. Singh. This marks a significant milestone for the company in providing access solutions for minimally invasive left-heart procedures.
BALTIMORE–(BUSINESS WIRE)–Protaryx Medical, an innovative medical device company developing differentiated access solutions for minimally invasive left-heart procedures, today announced the successful completion of the first U.S. commercial cases using its FDA-cleared Protaryx Transseptal Puncture Device. The procedures were performed at UC Davis Health in Sacramento, California, by interventional cardiologist Gagan D. Singh, M.D. The first two commercial cases were performed during left atri